Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • AstraZeneca pl pharmaceuticals news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Pharmaceuticals AstraZeneca agreed to pay the U.S. government $7.9 million to settle allegations that it engaged in a kickback scheme with Medco Health …

    Published on 2/23/2015
  • Celltrion Inc, J&J, Merck autoimmune news

    Celltrion Inc. (KOSDAQ:068270), Incheon, South Korea Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Autoimmune Johnson & Johnson said the U.S. Patent …

    Published on 2/23/2015
  • AC Immune, The Michael J. Fox Foundation For Parkinsons Research diagnostic, neurology news

    AC Immune S.A., Lausanne, Switzerland The Michael J. Fox Foundation For Parkinsons Research, New York, N.Y. Business: Diagnostic, Neurology The foundation awarded AC Immune an undisclosed grant to develop PET tracers …

    Published on 2/16/2015
  • Acorda autoimmune news

    Acorda Therapeutics Inc. (NASDAQ:ACOR), Ardsley, N.Y. Business: Autoimmune Coalition for Affordable Drugs filed an inter partes review with the U.S. Patent and Trademark Office challenging one of Acordas patents for …

    Published on 2/16/2015
  • AiCuris, Basilea, AstraZeneca, GlaxoSmithKline, Sanofi, Innovative Medicines Initiative infectious news

    AiCuris GmbH & Co. KG, Wuppertal, Germany Basilea Pharmaceutica AG (SIX:BSLN), Basel, Switzerland AstraZeneca plc (LSE:AZN;NYSE:AZN), London, U.K. GlaxoSmithKline plc (LSE:GSK;NYSE:GSK), London, U.K. Sanofi (Euronext:…

    Published on 2/16/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars Amgen filed a motion in the U.S. District Court for the Northern District of California seeking…

    Published on 2/16/2015
  • Bio/Med Investor Network other news

    Bio/Med Investor Network, Atlanta, Ga. Business: Other The angel investor network launched with about 40 initial member investors targeting early stage investments in bioscience, medical technologies and digital health …

    Published on 2/16/2015
  • Cytune cancer news

    Cytune Pharma S.A.S., Nantes, France Business: Cancer Investment firm PPF Group acquired an undisclosed minority stake in Cytune. PPF also committed to funding R&D related to Cytunes lead compound, CYP0150, as well as …

    Published on 2/16/2015
  • Galapagos, Agency for Innovation by Science and Technology, University of Antwerp, University of Leuven infectious news

    Galapagos N.V. (Euronext:GLPG; Pink:GLPYY), Mechelen, Belgium Agency for Innovation by Science and Technology, Brussels, Belgium University of Antwerp, Antwerp, Belgium University of Leuven, Leuven, Belgium Business: …

    Published on 2/16/2015
  • Gilead, Medecins du Monde infectious news

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Medecins du Monde (MDM), Paris, France Business: Infectious The Delhi High Court issued a ruling that Gileads patent application for HCV drug Sovaldi sofosbuvir be…

    Published on 2/16/2015
  • J&J pharmaceuticals, diagnostic news

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Business: Pharmaceuticals, Diagnostic Johnson & Johnson announced the creation of three dedicated groups to concentrate its R&D in disease interception, disease …

    Published on 2/16/2015
  • Myriad Genetics, Quest Diagnostics diagnostic news

    Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Quest Diagnostics Inc. (NYSE:DGX), Madison, N.J. Business: Diagnostic Myriad and Quest reached a settlement to dismiss litigation related to Myriads breast cancer…

    Published on 2/16/2015
  • Napo, Salix Pharmaceuticals Inc. gastrointestinal news

    Napo Pharmaceuticals Inc., San Francisco, Calif. Salix Pharmaceuticals Inc. (NASDAQ:SLXP), Raleigh, N.C. Business: Gastrointestinal Napo filed an opening brief in the Appellate Division of the Supreme Court of the State…

    Published on 2/16/2015
  • Astellas pharmaceuticals news

    Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Pharmaceuticals Astellas will make anonymized, patient-level clinical trial data available to researchers. An independent review panel will review and approve …

    Published on 2/9/2015
  • BioMotiv, Optikira LLC, University of California, University of Washington endocrine/metabolic, ophthalmic news

    BioMotiv LLC, Cleveland, Ohio Optikira LLC, Cleveland, Ohio University of California, San Francisco, Calif. University of Washington, Seattle, Wash. Business: Endocrine/Metabolic, Ophthalmic Drug development accelerator…

    Published on 2/9/2015
  • Invitae, Myriad Genetics, Pathway Genomics diagnostic news

    Invitae Corp., San Francisco, Calif. Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Pathway Genomics Corp., San Diego, Calif. Business: Diagnostic Myriad reached settlements to dismiss litigation with Invitae …

    Published on 2/9/2015
  • Pfizer, China National Pharmaceutical Group Corp. supply/service news

    Pfizer Inc. (NYSE:PFE), New York, N.Y. China National Pharmaceutical Group Corp. (Sinopharm), Beijing, China Business: Supply/Service Under an initial three-year agreement, Pfizers Pfizer Investment Co. Ltd. unit and …

    Published on 2/9/2015
  • Ablynx, GlaxoSmithKline antibodies news

    Ablynx N.V. (Euronext:ABLX), Ghent, Belgium GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Antibodies Ablynx said the Board of Appeal confirmed a 2010 decision from the Opposition Division of the …

    Published on 2/2/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars Novartis Sandoz Inc. generics unit filed a motion in the U.S. District Court for the Northern …

    Published on 2/2/2015
  • Egenix cancer news

    Egenix Inc., Millbrook, N.Y. Business: Cancer Egenix filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. Egenix is developing small molecules that inhibit eukaryotic translation …

    Published on 2/2/2015
  • Moderna Therapeutics, Valera infectious news

    Moderna Therapeutics Inc., Cambridge, Mass. Valera LLC, Cambridge, Mass. Business: Infectious Moderna launched Valera to develop mRNA vaccines and therapeutics to treat and prevent viral, bacterial and parasitic …

    Published on 2/2/2015
  • N4 Pharma drug delivery news

    N4 Pharma Ltd., Chellaston, U.K. Business: Drug delivery Newco N4 Pharma launched two technology platforms -- Cocrys and Nuvac -- for drug reformulation and vaccine delivery. The Cocrys process creates co-crystals of …

    Published on 2/2/2015
  • NewLink, GlaxoSmithKline, J&J, Merck, Pfizer, Sanofi, Global Alliance for Vaccine Immunization infectious news

    NewLink Genetics Corp. (NASDAQ:NLNK), Ames, Iowa GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Pfizer Inc.…

    Published on 2/2/2015
  • PharmAthene, Siga infectious news

    PharmAthene Inc. (NYSE-M:PIP), Annapolis, Md. Siga Technologies Inc. (NASDAQ:SIGA), New York, N.Y. Business: Infectious The Delaware Court of Chancery court ordered Siga to pay PharmAthene $194.6 million in a case …

    Published on 2/2/2015
  • Shire, Actavis generics, autoimmune news

    Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Actavis plc (NYSE:ACT), Dublin, Ireland Business: Generics, Autoimmune The U.S. Supreme Court granted a petition from Shire and remanded to a lower court Shires patent …

    Published on 2/2/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993